An in vitro stem cell model of human epiblast and yolk sac interaction.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
17 08 2021
Historique:
received: 10 10 2020
accepted: 03 08 2021
entrez: 17 8 2021
pubmed: 18 8 2021
medline: 9 10 2021
Statut: epublish

Résumé

Human embryogenesis entails complex signalling interactions between embryonic and extra-embryonic cells. However, how extra-embryonic cells direct morphogenesis within the human embryo remains largely unknown due to a lack of relevant stem cell models. Here, we have established conditions to differentiate human pluripotent stem cells (hPSCs) into yolk sac-like cells (YSLCs) that resemble the post-implantation human hypoblast molecularly and functionally. YSLCs induce the expression of pluripotency and anterior ectoderm markers in human embryonic stem cells (hESCs) at the expense of mesoderm and endoderm markers. This activity is mediated by the release of BMP and WNT signalling pathway inhibitors, and, therefore, resembles the functioning of the anterior visceral endoderm signalling centre of the mouse embryo, which establishes the anterior-posterior axis. Our results implicate the yolk sac in epiblast cell fate specification in the human embryo and propose YSLCs as a tool for studying post-implantation human embryo development

Identifiants

pubmed: 34403333
doi: 10.7554/eLife.63930
pii: 63930
pmc: PMC8370770
doi:
pii:

Banques de données

GEO
['GSE109555', 'GSE136447', 'GSE138012', 'GSE89303']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_PC_17230
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : DP1 HD104575
Pays : United States
Organisme : Wellcome Trust
ID : 207415/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1201/24
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : 1943755
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD100456
Pays : United States
Organisme : European Research Council
ID : 669198
Pays : International

Informations de copyright

© 2021, Mackinlay et al.

Déclaration de conflit d'intérêts

KM, BW, VS, CH, GH, TC, LP, SB, LV, MS, MZ No competing interests declared

Références

Curr Top Dev Biol. 2018;128:295-338
pubmed: 29477167
Nat Cell Biol. 2019 Jul;21(7):900-910
pubmed: 31263269
Cell Stem Cell. 2008 Aug 7;3(2):182-95
pubmed: 18682240
Development. 2015 Oct 15;142(20):3613
pubmed: 26487783
Stem Cell Res Ther. 2018 Mar 15;9(1):67
pubmed: 29544541
Science. 2019 Nov 15;366(6467):
pubmed: 31672918
Nat Commun. 2021 Jun 17;12(1):3679
pubmed: 34140473
Nature. 2020 Jan;577(7791):537-542
pubmed: 31830756
Stem Cells. 2014 Mar;32(3):636-48
pubmed: 24549638
Curr Opin Genet Dev. 2000 Aug;10(4):350-6
pubmed: 10889062
Nat Commun. 2018 Jan 24;9(1):360
pubmed: 29367672
Nat Protoc. 2012 Oct;7(10):1836-46
pubmed: 22976355
Development. 2017 Aug 1;144(15):2748-2763
pubmed: 28765214
Nature. 2013 Dec 12;504(7479):282-6
pubmed: 24172903
Nat Mater. 2017 Apr;16(4):419-425
pubmed: 27941807
Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Cell Rep. 2014 Oct 23;9(2):780-93
pubmed: 25373912
Nat Methods. 2014 Aug;11(8):847-54
pubmed: 24973948
Am J Anat. 1975 Oct;144(2):149-67
pubmed: 810017
Nature. 2016 Sep 1;537(7618):57-62
pubmed: 27556940
Nat Cell Biol. 2017 Oct;19(10):1164-1177
pubmed: 28945231
Nat Rev Mol Cell Biol. 2009 Feb;10(2):91-103
pubmed: 19129791
J Mol Biol. 2016 Feb 13;428(3):590-602
pubmed: 26802359
Development. 2019 Dec 16;146(24):
pubmed: 31740534
Development. 2019 Mar 25;146(6):
pubmed: 30814117
Stem Cell Reports. 2015 Dec 8;5(6):954-962
pubmed: 26626176
Dev Cell. 2016 Nov 7;39(3):302-315
pubmed: 27746044
Dev Cell. 2015 Nov 9;35(3):366-82
pubmed: 26555056
Biol Reprod. 2013 Jan 31;88(1):24
pubmed: 23153566
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
F1000Res. 2019 Mar 15;8:
pubmed: 31508207
Dev Cell. 2016 Oct 24;39(2):169-185
pubmed: 27720607
Nat Commun. 2020 Feb 10;11(1):810
pubmed: 32041960
Development. 2020 Jul 17;147(14):
pubmed: 32680920
Nat Cell Biol. 2016 Jun;18(6):700-708
pubmed: 27144686
Cold Spring Harb Perspect Biol. 2014 Jun 26;7(11):
pubmed: 24968703
Development. 2012 Mar;139(6):1059-69
pubmed: 22354839
Nature. 2020 Jun;582(7812):410-415
pubmed: 32528178
Dev Biol. 2013 Mar 1;375(1):54-64
pubmed: 23261930
Nature. 2019 Sep;573(7774):421-425
pubmed: 31511693
Development. 2005 Jun;132(11):2513-20
pubmed: 15857911
Dev Biol. 2005 Dec 15;288(2):363-71
pubmed: 16289026
Nature. 2019 Aug;572(7771):660-664
pubmed: 31435013
Nature. 2021 Oct;598(7879):195-199
pubmed: 34616073
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4753-E4761
pubmed: 28559354
Nat Commun. 2017 Aug 8;8(1):208
pubmed: 28785084
Anat Embryol (Berl). 1997 Jun;195(6):483-90
pubmed: 9193722
Nature. 2018 Jun;558(7708):132-135
pubmed: 29795348
J Biol Chem. 2004 Jul 2;279(27):28564-73
pubmed: 15082719
Nature. 2016 May 04;533(7602):251-4
pubmed: 27144363
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Dev Cell. 2008 Oct;15(4):509-20
pubmed: 18854136
Development. 2012 Mar;139(5):829-41
pubmed: 22318624
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cell. 1999 Jan 22;96(2):195-209
pubmed: 9988215
Cell. 2017 Apr 6;169(2):243-257.e25
pubmed: 28388409
Nature. 1971 Jan 8;229(5280):132-3
pubmed: 4923103
Stem Cells Dev. 2012 Aug 10;21(12):2273-87
pubmed: 22236333
Science. 2019 Nov 15;366(6467):
pubmed: 31672917
Development. 2012 Aug;139(16):2866-77
pubmed: 22791892
Nature. 2017 Dec 14;552(7684):239-243
pubmed: 29186120
Blood. 2002 Apr 1;99(7):2379-86
pubmed: 11895770
Nature. 1970 Sep 26;227(5265):1307-9
pubmed: 4916973
Development. 2000 May;127(9):1799-813
pubmed: 10751169

Auteurs

Kirsty Ml Mackinlay (KM)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.

Bailey At Weatherbee (BA)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.

Viviane Souza Rosa (V)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
National Laboratory for Embryonic Stem Cells (LaNCE), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.
MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Charlotte E Handford (CE)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
Centre for Trophoblast Research, University of Cambridge, Cambridge, United Kingdom.

George Hudson (G)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.

Tim Coorens (T)

Wellcome Sanger Institute, Cambridge, United Kingdom.

Lygia V Pereira (LV)

National Laboratory for Embryonic Stem Cells (LaNCE), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, Brazil.

Sam Behjati (S)

Wellcome Sanger Institute, Cambridge, United Kingdom.

Ludovic Vallier (L)

Wellcome - MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Marta N Shahbazi (MN)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, United Kingdom.

Magdalena Zernicka-Goetz (M)

Mammalian Embryo and Stem Cell Group, University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, United Kingdom.
Synthetic Mouse and Human Embryology Group, California Institute of Technology (Caltech), Division of Biology and Biological Engineering, Pasadena, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH